Figures and Tables
Figure or Table | Title |
---|---|
Section 1 – General Viral Hepatitis Surveillance Guidance | |
Table 1-1 | National notification and print criteria for hepatitis A, hepatitis B, and hepatitis C [Download PDFpdf icon| PPTppt icon] |
Table 1-2 | Viral hepatitis conditions with corresponding National Notifiable Diseases Surveillance System event codes and national notification criteria [Download PDFpdf icon| PPTppt icon] |
Table 1-3 | Epidemiologic risk behaviors, risk exposures, and groups at risk for hepatitis A, hepatitis B, and hepatitis C [Download PDFpdf icon| PPTppt icon] |
Section 2 – Hepatitis A Surveillance Guidance | |
Figure 2-1 | Typical serologic course of hepatitis A virus infection and recovery [Download PDFpdf icon| PPTppt icon] |
Table 2-1 | Interpretation of hepatitis A laboratory results [Download PDFpdf icon| PPTppt icon] |
Table 2-2 | CDC/CSTE case definition for hepatitis A, 2019 [Download PDFpdf icon| PPTppt icon] |
Figure 2-2 | Process for hepatitis A case ascertainment and classification [Download PDFpdf icon| PPTppt icon] |
Section 3 – Hepatitis B Surveillance Guidance | |
Figure 3-1 | Typical serologic course of acute hepatitis B to recovery [Download PDFpdf icon| PPTppt icon] |
Figure 3-2 | Typical serologic course of the progression to chronic hepatitis B [Download PDFpdf icon| PPTppt icon] |
Table 3-1 | Interpretation of hepatitis B laboratory results [Download PDFpdf icon| PPTppt icon] |
Table 3-2 | CDC/CSTE case definition for acute hepatitis B, 2012 [Download PDFpdf icon| PPTppt icon] |
Table 3-3 | CDC/CSTE case definition for chronic hepatitis B, 2012 [Download PDFpdf icon| PPTppt icon] |
Figure 3-3 | Process for acute and chronic hepatitis B case ascertainment and classification [Download PDFpdf icon| PPTppt icon] |
Table 3-4 | Considerations for hepatitis B cases who received a solid organ from a donor [Download PDFpdf icon| PPTppt icon] |
Table 3-5 | CDC/CSTE case definition for perinatal hepatitis B, 2017 [Download PDFpdf icon| PPTppt icon] |
Figure 3-4 | Process for perinatal hepatitis B case ascertainment and classification [Download PDFpdf icon| PPTppt icon] |
Table 3-6 | Common laboratory codes for hepatitis B post-vaccination testing [Download PDFpdf icon| PPTppt icon] |
Section 4 – Hepatitis C Surveillance Guidance | |
Figure 4-1 | Typical serologic course of hepatitis C virus infection [Download PDFpdf icon| PPTppt icon] |
Table 4-1 | Interpretation of hepatitis C laboratory results [Download PDFpdf icon| PPTppt icon] |
Table 4-2 | CDC/CSTE case definitions for acute and chronic hepatitis C, 2020 [Download PDFpdf icon| PPTppt icon] |
Figure 4-2 | Process for acute and chronic hepatitis C case ascertainment and classification [Download PDFpdf icon| PPTppt icon] |
Table 4-3 | Considerations for hepatitis C cases who were organ (or tissue) transplant recipients [Download PDFpdf icon| PPTppt icon] |
Table 4-4 | CDC/CSTE case definition for perinatal hepatitis C, 2018 [Download PDFpdf icon| PPTppt icon] |
Figure 4-3 | Process for perinatal hepatitis C case ascertainment and classification [Download PDFpdf icon| PPTppt icon] |
Section 5 – Additional Information and Resources | |
Table 5-1 | Classification of hepatitis C cases diagnosed concurrently with hepatitis A [Download PDFpdf icon| PPTppt icon] |
Table 5-2 | Person and case identification variables in the National Electronic Disease Surveillance System Base System [Download PDFpdf icon| PPTppt icon] |
Table 5-3 | Person and case identification variables via Health Level Seven case notification [Download PDFpdf icon| PPTppt icon] |
Table 5-4 | Variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via the National Electronic Telecommunications System for Surveillance [Download PDFpdf icon| PPTppt icon] |
Table 5-5 | Variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via the National Electronic Disease Surveillance System Base System [Download PDFpdf icon| PPTppt icon] |
Table 5-6 | Variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via Health Level Seven case notification [Download PDFpdf icon| PPTppt icon] |
Table 5-7 | Selections for variables indicating outbreak source for hepatitis A cases notified to the National Notifiable Diseases Surveillance System via Health Level Seven case notification [Download PDFpdf icon| PPTppt icon] |
Table 5-8 | Supplementary data sources [Download PDFpdf icon| PPTppt icon] |
Table 5-9 | Use of supplementary data sources for case ascertainment, investigation, characterization, and for monitoring of infection trends and disease-related outcomes [Download PDFpdf icon| PPTppt icon] |
Table 5-10 | International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes for hepatitis A, hepatitis B, and hepatitis C for clinical diagnosis and cause of death coding [Download PDFpdf icon| PPTppt icon] |
Section 6 – Appendices | |
Figure 6-1 | Testing algorithm for the Ortho VITROS hepatitis B surface antigen initial assay [Download PDFpdf icon| PPTppt icon] |
Page last reviewed: September 21, 2021